Search research articles
Contact Us
Filters
Showing results (111-120 of 200) with videos related to
Page
of 20
Sort By:
Clinical Colorectal Cancer
|
January 16, 2025
Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial
Julien Taieb, Marwan Fakih, Josep Tabernero, et al.
Advances in Radiation Oncology
|
January 24, 2022
A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses
Joseph Chao, Ting-Fang He, Massimo D'Apuzzo, et al.
International Journal of Cancer
|
July 14, 2020
A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer
Takatoshi Matsuyama, Raju Kandimalla, Toshiaki Ishikawa, et al.
Annals of Surgical Oncology
|
December 3, 2024
ASO Visual Abstract: Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in Refractory Colorectal and Appendiceal Carcinomatosis-Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial
Muhammad Talha Waheed, Nora Ruel, Richard L Whelan, et al.
Annals of Surgical Oncology
|
September 13, 2024
Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial
Muhammad Talha Waheed, Nora Ruel, Richard L Whelan, et al.
Frontiers in Oncology
|
January 31, 2025
Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer
Julien Taieb, Marwan Fakih, Gabor Liposits, et al.
Current Treatment Options in Oncology
|
September 26, 2024
Clinical Trial Data Review of the Combination FTD/TPI + Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer
Thierry André, Eric Van Cutsem, Julien Taieb, et al.
JCI Insight
|
January 25, 2021
Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis
Maryam Aftabizadeh, Yi-Jia Li, Qianqian Zhao, et al.
Journal for Immunotherapy of Cancer
|
April 24, 2023
Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE)
Marwan Fakih, Wael Harb, Daruka Mahadevan, et al.
Journal of Gastrointestinal Oncology
|
January 5, 2018
Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus
Andrew Kennedy, Daniel B Brown, Jonas Feilchenfeldt, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 200) with videos related to
Sort By:
Page
of 20
Clinical Colorectal Cancer
|
January 16, 2025
Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial
Julien Taieb, Marwan Fakih, Josep Tabernero, et al.
Advances in Radiation Oncology
|
January 24, 2022
A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses
Joseph Chao, Ting-Fang He, Massimo D'Apuzzo, et al.
International Journal of Cancer
|
July 14, 2020
A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer
Takatoshi Matsuyama, Raju Kandimalla, Toshiaki Ishikawa, et al.
Annals of Surgical Oncology
|
December 3, 2024
ASO Visual Abstract: Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in Refractory Colorectal and Appendiceal Carcinomatosis-Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial
Muhammad Talha Waheed, Nora Ruel, Richard L Whelan, et al.
Annals of Surgical Oncology
|
September 13, 2024
Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial
Muhammad Talha Waheed, Nora Ruel, Richard L Whelan, et al.
Frontiers in Oncology
|
January 31, 2025
Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer
Julien Taieb, Marwan Fakih, Gabor Liposits, et al.
Current Treatment Options in Oncology
|
September 26, 2024
Clinical Trial Data Review of the Combination FTD/TPI + Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer
Thierry André, Eric Van Cutsem, Julien Taieb, et al.
JCI Insight
|
January 25, 2021
Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis
Maryam Aftabizadeh, Yi-Jia Li, Qianqian Zhao, et al.
Journal for Immunotherapy of Cancer
|
April 24, 2023
Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE)
Marwan Fakih, Wael Harb, Daruka Mahadevan, et al.
Journal of Gastrointestinal Oncology
|
January 5, 2018
Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus
Andrew Kennedy, Daniel B Brown, Jonas Feilchenfeldt, et al.
Page
of 20